TERAPIA

RHINXYL HA ADULTS 1MG/ML NASAL SPRAY

You're reading an Auto-translation.

Composition.

The active substance is xylometazoline hydrochloride. 1 ml of RHINXYL HA 1 mg/ml nasal spray, solution contains 1 mg xylometazoline hydrochloride. One spray (140 µl) contains 0.140 mg xylometazoline hydrochloride. Excipients are purified seawater, potassium dihydrogen phosphate, sodium hyaluronate, purified water.

Therapeutic indications.

RHINXYL nasal spray, solution belongs to a group of medicines for the treatment of nasal diseases, called sympathomimetics. It contains xylometazoline hydrochloride, which helps constrict the blood capillaries in the nose, thereby reducing nasal mucosal congestion.

RHINXYL solution also contains hyaluronic acid (as sodium hyaluronate), which protects and moisturizes the nasal mucosa.

RHINXYL solution is used for:

- reducing nasal mucosal congestion caused by inflammation of the nasal mucosa (rhinitis) or inflammation of the sinus mucosa (sinusitis).

Dosage and administration.

Always use this medicine exactly as described in this leaflet or as your doctor or pharmacist has told you. Talk to your doctor or pharmacist if you are not sure.

Dosage

Adults and adolescents over 12 years of age: 1 spray of RHINXYL HA 1 mg/ml nasal spray, solution in each nostril, up to 3 times a day. RHINXYL HA 1 mg/ml nasal spray, solution should not be used for more than 5 days, unless otherwise prescribed by a doctor. Use can be repeated if treatment has been interrupted for several days. Long-term use of RHINXYL HA 1 mg/ml nasal spray, solution can lead to atrophy of the nasal mucosa. Therefore, in cases of chronic disorders, the medicine can only be used under medical supervision.

Doses higher than the recommended doses should not be used.

If after 3 days of continuous treatment, you do not feel better or feel worse, you should consult a doctor.

Precautions.

Before using RHINXYL HA 1 mg/ml nasal spray, solution, talk to your doctor or pharmacist:

- if you are being treated with monoamine oxidase inhibitors (MAOIs) (e.g., tranylcypromine and moclobemide, which are used for the treatment of depression) or have used MAOIs within the last 2 weeks, tricyclic or tetracyclic antidepressants, or other medicines that can increase blood pressure

- if you are using medicines from the beta-blocker or alpha-blocker group (commonly used to lower blood pressure or in the treatment of benign prostatic hypertrophy (enlargement))

- if you have severe cardiovascular disease (e.g., coronary heart disease, high blood pressure)

Special warnings.

Pregnancy, breastfeeding and fertility

If you are pregnant or breastfeeding, think you may be pregnant or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine. There are no adequate data on the use of xylometazoline hydrochloride in pregnant women. Therefore, RHINXYL HA 1 mg/ml nasal spray, solution should not be used during pregnancy. This medicine should not be used during breastfeeding, as it is not known whether xylometazoline hydrochloride is excreted in human milk.

Driving and using machines

No reduction in the ability to drive or use machines is expected if the medicine is used according to instructions.

Packaging. 10 ml solution in a white plastic bottle, equipped with a dosing pump, with an applicator tip and a protective cap, packed in a box.

Page updated on: 08.06.2021